Information Provided By: 
Fly News Breaks for October 26, 2015
ATHN
Oct 26, 2015 | 07:49 EDT
Oppenheimer believes that athenahealth's Q3 results show why investors should own the stock. The firm thinks the results show that the company can continue to grow, while changes in the regulatory environment should significantly increase the number of doctors who are interested in its offerings. The firm thinks the problems being experienced by other healthcare providers will cause more investors to become interested in athenahealth. It raised its price target on the name to $185 from $168 and keeps an Outperform rating on the shares.
News For ATHN From the Last 2 Days
There are no results for your query ATHN
